Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFor many people starting Wegovy, questions about mental health come up early. Semaglutide acts on GLP-1 receptors that are found not just in the gut but also in areas of the brain involved in mood, reward and motivation — which means its effects on mental health are a reasonable thing to ask about. This is a prescription-only medicine, and how it might interact with your particular mental health history is one of the things a clinical assessment is there to explore.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide works by activating GLP-1 receptors. Most people know that as a gut story, slowed gastric emptying, reduced appetite, steadier blood sugar. What surprises many people is that GLP-1 receptors are also found in the brain, including in the hypothalamus and limbic system, areas closely tied to hunger, mood and emotional regulation.
That dual presence means semaglutide almost certainly has some effect on brain chemistry, though exactly how those effects translate into everyday mood is still being researched. Early observational data have prompted real scientific interest: some analyses suggest lower rates of depression and anxiety among people taking GLP-1 medicines compared with other weight-loss interventions. Whether that is a direct pharmacological effect, a consequence of weight loss itself, or some combination of both is not yet settled. The emerging evidence on semaglutide and mental health benefits is genuinely promising, but it is evidence-in-progress rather than a proven outcome.
The practical point for someone starting treatment is this: your mental health history matters to your prescriber, both because it shapes the likely experience of treatment and because there are some presentations that require more careful monitoring.
The NHS patient information for semaglutide lists low mood, mood changes and, importantly, thoughts of self-harm or suicide as side effects that require prompt medical attention. These are listed as uncommon rather than common, but uncommon still means real. If you notice a significant shift in your mood after starting or after a dose increase, that is worth raising with a clinician rather than waiting to see whether it passes.
On the other side of the ledger, fatigue and headache (both common, particularly early in treatment) can feel like they are affecting mood even when the mechanism is more straightforward. Many people find that staying well hydrated and keeping protein intake steady during the weeks when appetite is lowest makes a noticeable difference to how they feel day to day. That is a practical step worth building into a routine.
The broader picture of health issues associated with Wegovy covers the gastrointestinal effects, pancreatitis warning signs and other things to monitor. From a mental health perspective, the key habit is simple: before each weekly injection, take thirty seconds to notice how your mood has been over the past week. It does not need to be formal. A brief check-in with yourself, the same way you might note whether nausea has improved, gives you something concrete to report to your prescriber. Any pattern of worsening low mood should be flagged promptly, the NHS patient information on semaglutide is clear that these symptoms warrant medical advice.
Having a history of depression or anxiety does not automatically exclude someone from treatment with Wegovy. It does mean the clinical picture needs to be looked at carefully. If you are currently taking antidepressants or other psychiatric medicines, your prescriber will want to understand how stable your condition is and whether there are any known interactions to consider.
People in recovery from eating disorders are a group where particular caution applies. The appetite-suppressing effects of semaglutide, combined with a focus on food restriction, can be difficult territory. The prescriber's assessment will take this into account. If you have any concerns about how your relationship with food might be affected, that conversation should happen before treatment begins, not after.
For most people with well-managed mental health conditions, the net effect of treatment is positive: sustained weight reduction, better sleep in those with obesity-related sleep apnoea, and reduced physical health burden all tend to support rather than undermine mental wellbeing. Exploring the health benefits of Wegovy gives a fuller sense of how physical and mental effects interact over time. The question of whether Wegovy is a healthy choice overall is also worth reading alongside this page if you are weighing up the full picture.
Because this is a prescription-only medicine, a prescriber has to make the call on suitability, and mental health history is part of that conversation, not a box to rush past. At nume, every consultation is read by a GPhC-registered prescriber, not processed by software. That means the details you share about your mental health are seen by a clinician who can weigh them properly. You can learn more about how our clinical team approaches assessments on the clinical team page.
During treatment, aftercare support is available seven days a week. If mood changes appear, having a channel to raise them promptly matters. The full Wegovy treatment overview sets out what the ongoing clinical relationship looks like in practice. If cost is a consideration alongside everything else, the Wegovy price comparison explains what is typically included in a private prescription and what to check for.
Mental health is rarely one thing, and semaglutide does not act on it in a single predictable way. What is clear from the evidence is that it warrants honest attention, both before starting and throughout treatment. If you would like to discuss your own situation with a prescriber, speaking to our prescribers through a free consultation is a straightforward way to start that conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.